Adage Capital Partners’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,500,000	Closed	-$3.85M	–	755
2018 Q4	$3.85M	Hold	5,500,000	–	–	0.01%	630
2018 Q3	$6.76M	Hold	5,500,000	–	–	0.02%	602
2018 Q2	$6.11M	Hold	5,500,000	–	–	0.01%	637
2018 Q1	$11.1M	Hold	5,500,000	–	–	0.03%	537
2017 Q4	$6.6M	Buy	5,500,000 +3,400,000	+162%	+$4.64M	0.01%	608
2017 Q3	$2.65M	Hold	2,100,000	–	–	0.01%	663
2017 Q2	$2.79M	Buy	2,100,000 +1,000,000	+91%	+$1.45M	0.01%	656
2017 Q1	$2.05M	Sell	1,100,000 -1,000,000	-48%	-$4.52M	0.01%	662
2016 Q4	$10.9M	Hold	2,100,000	–	–	0.03%	517
2016 Q3	$11.7M	Hold	2,100,000	–	–	0.03%	492
2016 Q2	$11.7M	Buy	2,100,000 +850,000	+68%	+$4.46M	0.03%	483
2016 Q1	$5.5M	Buy	1,250,000 +350,000	+39%	+$1.44M	0.01%	597
2015 Q4	$5.42M	Buy	+900,000	New	+$6.11M	0.01%	596